health care costs seksan Mongkhonkhamsao/Getty Images

Closing the TB Funding Gap

It has been 25 years since tuberculosis was declared a global-health emergency. But while world leaders generally agree on the need to invest in solutions, surprisingly few new TB medicines are being developed.

NEW YORK – In the 25 years since tuberculosis (TB) was declared a global-health emergency, policymakers and health-care professionals have devoted considerable time discussing ways to eliminate it. Over the last two years alone, they have held talks in Moscow, Brussels, New Delhi, and, most recently, in September at the United Nations General Assembly in New York, where they convened for the first-ever high-level meeting on TB containment.

But while leaders generally agree on the need to invest in solutions, we have surprisingly few TB medicines to show for our quarter-century of effort. The 250 million people who have been infected since 1993 – and the millions who have died – deserved better.

TB is the world’s deadliest infection, and it has been with us for a very long time. Researchers theorize that humans first acquired TB in Africa about 5,000 years ago, and that the disease then swiftly spread along trade routes to nearly every corner of the globe. Today, TB is among the world’s leading causes of death, killing approximately 1.6 million people in 2017, which was only slightly fewer than the year before. But the effectiveness of TB treatments is declining, raising concerns that drug-resistant strains are becoming more virulent.

We hope you're enjoying Project Syndicate.

To continue reading, subscribe now.


Get unlimited access to PS premium content, including in-depth commentaries, book reviews, exclusive interviews, On Point, the Big Picture, the PS Archive, and our annual year-ahead magazine.

Help make our reporting on global health and development issues stronger by answering a short survey.

Take Survey;
  1. solana105_JUANMABROMATAAFPGettyImages Juan Mabromata/AFP/Getty Images

    The Lost Spirit of the G20

    Javier Solana

    As Japan prepares to host its first G20 leaders’ summit later this month, little remains of the open and cooperative spirit that marked the first such gathering in 2008. But although the United States will most likely continue its protectionist drift, other G20 countries should use the occasion to make a clear case for free trade.

  2. velasco94_YoustGettyImages_headswithbooksstaring Youst/Getty Images

    The Experts We Need

    Andrés Velasco

    Policy gurus spend too much time with others like them – top civil servants, high-flying journalists, successful businesspeople – and too little time with ordinary voters. If they could become “humble, competent people on a level with dentists,” as John Maynard Keynes once suggested, voters might identify with them and find them trustworthy.

  3. benami152_KiyoshiOtaPoolGettyImages_trumpmelaniaeatinginJapan Kiyoshi Ota - Pool/Getty Images

    Don’t Feed the Donald

    Shlomo Ben-Ami

    For Japanese Prime Minister Shinzo Abe, appeasing US President Donald Trump is not so much a choice as a necessity: he must prove to Japan’s people and their neighbors, particularly the Chinese, that he knows how to keep Trump on his side. But Abe's strategy won't work with a US administration as fickle and self-serving as Trump’s.

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated cookie policy and privacy policy.